Senseonics Holdings Debt to Equity Ratio 2015-2023 | SENS
Current and historical debt to equity ratio values for Senseonics Holdings (SENS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Senseonics Holdings debt/equity for the three months ending December 31, 2023 was 1.15.
| Senseonics Holdings Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.10B | $0.04B | 2.86 |
| 2023-09-30 | $0.10B | $0.05B | 1.96 |
| 2023-06-30 | $0.10B | $0.05B | 1.92 |
| 2023-03-31 | $0.09B | $0.06B | 1.46 |
| 2022-12-31 | $0.18B | $-0.00B | -69.97 |
| 2022-09-30 | $0.20B | $-0.02B | -13.13 |
| 2022-06-30 | $0.16B | $0.02B | 10.00 |
| 2022-03-31 | $0.28B | $-0.09B | -3.10 |
| 2021-12-31 | $0.38B | $-0.19B | -2.07 |
| 2021-09-30 | $0.49B | $-0.27B | -1.82 |
| 2021-06-30 | $0.55B | $-0.31B | -1.75 |
| 2021-03-31 | $0.38B | $-0.19B | -2.05 |
| 2020-12-31 | $0.18B | $-0.14B | -1.25 |
| 2020-09-30 | $0.10B | $-0.05B | -1.85 |
| 2020-06-30 | $0.08B | $-0.04B | -2.03 |
| 2020-03-31 | $0.08B | $-0.05B | -1.72 |
| 2019-12-31 | $0.14B | $-0.01B | -16.35 |
| 2019-09-30 | $0.14B | $0.03B | 5.59 |
| 2019-06-30 | $0.08B | $0.02B | 5.49 |
| 2019-03-31 | $0.09B | $0.04B | 1.95 |
| 2018-12-31 | $0.09B | $0.07B | 1.25 |
| 2018-09-30 | $0.11B | $0.08B | 1.39 |
| 2018-06-30 | $0.10B | $0.11B | 0.97 |
| 2018-03-31 | $0.09B | $-0.01B | -6.91 |
| 2017-12-31 | $0.04B | $0.01B | 5.32 |
| 2017-09-30 | $0.04B | $0.02B | 1.70 |
| 2017-06-30 | $0.04B | $0.01B | 2.92 |
| 2017-03-31 | $0.03B | $-0.02B | -1.96 |
| 2016-12-31 | $0.03B | $-0.01B | -5.57 |
| 2016-09-30 | $0.02B | $0.00B | 5.63 |
| 2016-06-30 | $0.02B | $0.01B | 1.68 |
| 2016-03-31 | $0.02B | $0.02B | 0.91 |
| 2015-12-31 | $0.02B | $-0.01B | -1.56 |
| 2015-09-30 | $0.00B | $0.00B | -1.04 |
| 2015-06-30 | $0.00B | $0.00B | -1.02 |
| 2015-03-31 | $0.00B | $0.00B | -4.77 |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | $0.00B | -1.30 |
| 2014-06-30 | $0.00B | $0.00B | 0.41 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.221B | $0.022B |
| Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $38.774B | 21.57 |
| Inspire Medical Systems (INSP) | United States | $7.306B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.489B | 0.00 |
| 10x Genomics (TXG) | United States | $3.450B | 0.00 |
| Axonics (AXNX) | United States | $3.420B | 0.00 |
| Enovis (ENOV) | United States | $3.031B | 23.03 |
| Azenta (AZTA) | United States | $2.816B | 229.50 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.769B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.644B | 0.00 |
| Privia Health (PRVA) | United States | $2.114B | 93.79 |
| Schrodinger (SDGR) | United States | $1.760B | 0.00 |
| Phreesia (PHR) | United States | $1.275B | 0.00 |
| Omnicell (OMCL) | United States | $1.251B | 30.62 |
| Definitive Healthcare (DH) | United States | $0.829B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.502B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.313B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.313B | 0.00 |
| Pulmonx (LUNG) | United States | $0.289B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.171B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.150B | 0.00 |
| Augmedix (AUGX) | United States | $0.147B | 0.00 |
| TruBridge (TBRG) | United States | $0.119B | 5.06 |
| Outset Medical (OM) | United States | $0.116B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.115B | 0.00 |
| 111 (YI) | China | $0.084B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.075B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | China | $0.051B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.042B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| ETAO (ETAO) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.019B | 0.00 |
| Akili (AKLI) | United States | $0.018B | 0.00 |
| Biotricity (BTCY) | United States | $0.014B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |